首站-论文投稿智能助手
典型文献
Dysregulated RUNX1 Predicts Poor Prognosis by Mediating Epithelialmesenchymal Transition in Cervical Cancer
文献摘要:
Objective:Runt-related transcription factor 1(RUNX1)has been proven to be over-expressed and vital in many malignancies.However,its role in cervical cancer is still unclear.Methods:Some online databases(Oncomine,GEPIA,UALCAN,LinkedOmics,and others)were used to explore the expression level,prognostic significance,and gene mutation characteristics of RUNX1 in cervical cancer.The protein levels of RUNX1 in cervical cancer were measured by immunohistochemistry(IHC).The functional changes of cervical cancer cells were measured in vitro after decreasing RUNX1.Results:Bioinformatic results revealed that RUNX1 was upregulated in cervical cancer compared to normal tissues.Moreover,over-expression of RUNX1 was significantly correlated with cervical cancer patients'clinical parameters(e.g.,individual cancer stages,patients'age,nodal metastasis status,and others).Meanwhile,functional enrichment analysis of RUNX1-related genes indicated that RUNX1 was mainly involved in the epithelial-mesenchymal transition(EMT)process in cervical cancer.Furthermore,RUNX1 may be upregulated by hsa-miR-616-5p and hsa-miR-766 identified by miRDB,TargetScan,and miRWalk.Finally,RUNX1 was upregulated in cervical cancer compared to normal tissues by IHC in collected cervical cancer samples.The invasion and migration abilities of cervical cancer cells were significantly reduced by repressing EMT after knocking down RUNX1 in vitro.Conclusion:RUNX1 was highly expressed in cervical cancer,and upregulated RUNX1 could significantly promote the invasive abilities of cervical cancer cells by inducing EMT.Therefore,RUNX1 may be a potential biomarker for early diagnosis and targeted therapy of cervical cancer.
文献关键词:
作者姓名:
Ling-ling ZHENG;Lei CAI;Xiao-qing ZHANG;Zhe LEI;Chang-sheng YI;Xing-dang LIU;Ji-gang YANG
作者机构:
Department of Nuclear Medicine,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China;Department of Nuclear Medicine,Huashan Hospital,Fudan University,Shanghai 200040,China;Reproductive Medicine Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Thoracic Surgery,the Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Zhengzhou 450003,China
引用格式:
[1]Ling-ling ZHENG;Lei CAI;Xiao-qing ZHANG;Zhe LEI;Chang-sheng YI;Xing-dang LIU;Ji-gang YANG-.Dysregulated RUNX1 Predicts Poor Prognosis by Mediating Epithelialmesenchymal Transition in Cervical Cancer)[J].当代医学科学(英文),2022(06):1285-1296
A类:
Mediating,Epithelialmesenchymal
B类:
Dysregulated,RUNX1,Predicts,Poor,Prognosis,by,Transition,Cervical,Cancer,Objective,Runt,transcription,has,been,proven,expressed,vital,many,malignancies,However,its,role,cervical,cancer,still,unclear,Methods,Some,online,databases,Oncomine,GEPIA,UALCAN,LinkedOmics,others,were,used,explore,expression,prognostic,significance,mutation,characteristics,protein,levels,measured,immunohistochemistry,IHC,functional,changes,cells,vitro,after,decreasing,Results,Bioinformatic,results,revealed,that,was,upregulated,compared,normal,tissues,Moreover,significantly,correlated,patients,clinical,parameters,individual,stages,nodal,metastasis,status,Meanwhile,enrichment,analysis,genes,indicated,mainly,involved,epithelial,transition,EMT,process,Furthermore,may,hsa,5p,identified,miRDB,TargetScan,miRWalk,Finally,collected,samples,invasion,migration,abilities,reduced,repressing,knocking,down,Conclusion,highly,could,promote,invasive,inducing,Therefore,potential,biomarker,early,diagnosis,targeted,therapy
AB值:
0.521498
相似文献
Overexpression of Protein Phosphatase 2 Regulatory Subunit B"Alpha Promotes Glycolysis by Regulating Hexokinase 1 in Hepatocellular Carcinoma
JIAO Ning;JI Wan Sheng;ZHANG Biao;SHANG Yu Kui;ZHANG Yu Chen;YU Wei Qun;JIN Hai Long;LI Chao;ZHANG Cheng Ying;YAN Cheng;YUE Wen;ZHANG Qing-Weifang Medical university,Weifang 261053,Shandong,China;Department of Organ Transplantation,The Third Medical Center of PLA General Hospital,Beijing 100039,China;Clinical Research Center,Affiliated Hospital of Weifang Medical University,Weifang 261042,Shandong,China;Stem Cell and Regenerative Medicine Lab,Institute of Health Service and Transfusion Medicine,Beijing 100850,China;Department of Basic Medical Sciences,School of Medicine,Tsinghua University,Beijing 100083,China;Senior Department of Ophthalmology,The Third Medical Center of PLA General Hospital,Beijing 100039,China;Department of General Practice,The Third Medical Center of PLA General Hospital,Beijing 100039,China
Clinical significance of serum IgM and IgG levels in COVID-19 patients in Hubei Province, China ☆
Bai Zhenjiang;Li Qing;Chen Qinghui;Niu Changming;Wei Yu;Huang Hanpeng;Zhao Wei;Chen Nian;Yao Xin;Zhang Qiang;Mu Chuanyong;Feng Jian;Zhu Chuanlong;Li Zhuo;Ding Ming;Feng Binhui;Jin Chaochao;Lu Xiang;Yang Yi;Wu Shuiyan;Shu Xiaochen;Hu Lifang;Qiu Haibo;Huang YingZi-Pediatric Intensive Care Unit, Children’s Hospital of Soochow University, Suzhou, Jiangsu 215025, China;Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China;Department of Infectious Diseases, Children’s Hospital of Soochow University, Suzhou, Jiangsu 215025, China;Department of Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210011, China;Department of Respirology, Jiangsu Province Hospital of TCM, Nanjing, Jiangsu 210046, China;Department of Respirology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China;Department of Critical Care Medicine, Sir Run Hospital Nanjing Medical University, Nanjing, Jiangsu 211112, China;Department of Infectious Diseases, The Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 211103, China;Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 211103, China;Department of Respirology, Southeast University Zhongda Hospital, Nanjing, Jiangsu 210009, China;Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China;Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226019, China;Department of Emergency, Children’s Hospital of Nanjing Medical University, Nanjing, Jiangsu 210008, China;Department of Critical Care Medicine, Huangshi Central Hospital, Huangshi, Hubei 435002, China;Department of Oncology, Huangshi Hospital of TCM (Infectious Disease Hospital, Huangshi, Hubei 435002, China;Department of Geriatric Medicine, Sir Run Hospital Nanjing Medical University, Nanjing, Jiangsu 211112, China;Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, Jiangsu 215031, China;Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215031, China
Nutritional Risk Screening with NRS2002 among Hospitalized Cancer Patients in China
Ming Ming Zhou;Tian Tian Wu;Yu Han Wang;Yuan Lin Zou;Ke Di Xu;Jiu Wei Cui;Zeng Ning Li;Jun Qiang Chen;Ming Liu;Zeng Qing Guo;Hong Xia Xu;Han Ping Shi;Chun Hua Song;Investigation on Nutrition Status and Clinical Outcome of Common Cancers(INSCOC)Group-Department of Epidemiology and Statistics,College of Public Health,Zhengzhou University,Zhengzhou 450001,Henan,China;Cancer Center of the First Hospital of Jilin University,Changchun 130021,Jilin,China;Department of Clinical Nutrition,The First Hospital of Hebei Medical University,Shijiazhuang 050031,Hebei,China;Department of Gastrointestinal Surgery,First Affiliated Cancer Hospital of Guangxi Medical University,Nanning 530021,Guangxi,China;Department of General Surgery,The Fourth Affiliated Hospital,Harbin Medical University,Harbin 150000,Heilongjiang,China;Department of Medical Oncology,Fujian Cancer Hospital&Fujian Medical University Cancer Hospital,Fuzhou 350014,Fujian,China;Department of Clinical Nutrition,Daping Hospital,Army Medical University(Third Military Medical University),Chongqing 400042,China;Department of Gastrointestinal Surgery/Department of Clinical Nutrition,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China;Key Laboratory of Cancer FSMP for State Market Regulation,Beijing 100038,China
Data Mining and Systems Pharmacology to Elucidate Effectiveness and Mechanisms of Chinese Medicine in Treating Primary Liver Cancer
ZHANG Zhen;LI Jun-wei;ZENG Pu-hua;GAO Wen-hui;TIAN Xue-fei-Department of Internal Medicine,College of Integrated Chinese and Western Medicine of Hunan University of Chinese Medicine,Changsha,410208,China;Hunan Key Laboratory of TCM Prescription and Syndromes Translational Medicine,Hunan University of Chinese Medicine,Changsha,410208,China;Department of Pharmacy,Shenzhen People's Hospital,the Second Clinical Medical College,Jinan University;the First Affiliated Hospital,Southern University of Science and Technology,Shenzhen,518020,Guangdong Province, China;Department of Oncology,Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine,Changsha,410006, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。